Year-over-year, this metric grew by 20.0%, from $180.00K to $216.00K. Over 2 years (FY 2023 to FY 2025), Interest Paid shows a downward trend with a -15.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $63.25K | $63.25K | $63.25K | $63.25K | $64.50K | $64.50K | $64.50K | $64.50K | $180.00K | $0.00 | $0.00 | $0.00 | $216.00K |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.0% | +0.0% | +0.0% | +0.0% | +179.1% | -100.0% | — | — | — |
| YoY Change | — | — | — | — | +2.0% | +2.0% | +2.0% | +2.0% | +179.1% | -100.0% | -100.0% | -100.0% | +20.0% |